Sotera Health Co

The company provides outsourced terminal sterilization solutions, microbiological and analytical lab testing, and technical advisory services. It operates primarily through two segments: Sterilization Services (comprising Sterigenics and Nordion) and Lab Testing and Advisory Services (Nelson Labs). Sterigenics delivers terminal sterilization using gamma irradiation, ethylene oxide processing, and electron-beam irradiation. Nordion supplies Cobalt-60 radiation sources and manufactures gamma irradiation units for industrial sterilization and oncology applications. Nelson Labs conducts testing across healthcare product life cycles, including sterility assurance, biocompatibility, and regulatory compliance consulting. The company primarily serves medical device and pharmaceutical manufacturers, alongside food safety and advanced commercial customers.

Operations encompass a network of 62 facilities worldwide, including 48 sterilization facilities located across 13 countries as well as specialized laboratories and processing centers in North America and Europe. The enterprise supports customers in over 50 countries and employs more than 3,000 workers globally. Its headquarters is not stated in the provided text.

Summary of the business section of Sotera Health's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we employed over 3,000 employees worldwide.”